Medical Xpress featured Babar Khan, M.D., M.S., and Sikandar Khan, D.O., M.S., of Regenstrief Institute for their multi-center randomized controlled trial testing slow-tempo music to address delirium in critically ill older adults. The study, published in JAMA Internal Medicine, found that twice-daily slow-tempo music did not reduce delirium, pain or anxiety compared with a silence-track control but demonstrated the feasibility of app-based music delivery in the intensive care unit and highlighted potential subgroups for further study.
-
Research
- Experts
In The News
View AllAP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View AllOffice of Strategic Innovation helps connect startups with research expertise
Moving healthcare innovations from promising ideas to real-world impact requires...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Collaboration
Generating Evidence Across the Full Arc of Disease
Regenstrief Institute x Merck The Question Clinical trials establish whether...
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief, Triomics and Indiana University Health, supported by an independent...
- Experts



